2Barondes SH,Cooper DN,Gitt MA,et al.Primary structure and function of a large family of animal lectins[J].J Biol Chem,1994,269(33):20807-20810.
3Honjo Y,Nangia-Makker P,Inohara H,et al.Down-regulation of Galectin-3 suppresses tumorigenicity of human breast carcinoma cells[J].Clin Cancer Res,2001,7(3):661-668.
4Yu F,Finley RL,Raz A,et al.Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria[J].J Biol Chem,2002,277(18):15819-15827.
5Parise LV,Lee J,Juliano RL.New aspects of integrin signaling in cancer[J].Semin Cancer Biol,2000,10(6):407-414.
6Khaldoyanidi SK,Glinsky VV,Sikora L,et al.MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-Galectin-3 interactions[J].J Biol Chem,2003,278(6):4127-4134.
9Ochieng J,Fridman R,Nangia-Makker P,et al.Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9[J].Biochemistry,1994,33(47):14109-14114.
10Zucker S,Cao J,Chen WT.Critical appraisal of the use matrix metalloproteinase inhibitors in cancer treatment[J].Oncogene,2000,19(56):6642-6650.
5WHO. 1994 World Health Statistics Annual. Geneve: WHO, 1995 ,B4-B347.
6Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer.Inst, 2001,93:226-233.
7Pisani P, Parkin DM, Ferlay J, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999,83: 18-29.
8WHO. 1973-1976 World Health Statistics Annual. Geneve: WHO,1976. 188-719.
10Barondes S H, Cooper D N, Gitt M A, et al. Galectins. Structure and function of a large family of animal lectins[ J]. J Biol Chem, 1994, 269 (33) : 20807 -20810.
3Musgrove EA,Caldon CE,Barraclough J,et al.CyclinD as a therapeutic target in cancer[J].Nat Rev Cancer,2011,11(8):558-572.
4Kilpatrick DC.Animal Lectins:A Historical Introduction and Overview[J].Biochim Biophys Acta,2002,1572(2-3):187-197.
5Miyazaki J,Hokari R,Kato S,et al.Increased expression of Galectin-3 in primary gastric cancer and the metastatic lymph nodes[J].Oncol Rep,2002,9(6):1307-1312.
6Okada K,Shimura T,Suchiro T,et al.Reduced Galectin-3 expression is indicator of unfavorable prognosis in gastric cancer[J].Anticancer Res,2006,26(2B):1369-1376.
8Han S,Kim HY,Park K,et al.Expression of P27Kipl and CyclinD1 proteins is inversely correlated and is associated with poor clinical outcome in human gastric cancer[J].Surg Oncol,1999,71(3):147-154.
9Lan B,Xu DP,Lin YK.Expression of cyclinD1 and P53 in gastric carcinoma[J].pract J Cancer,2002,17(1):26-28.
